• DMH-1 Enables Precision in BMP Pathway Control for Translati

  2026-05-09

  Explore how DMH-1, a selective ALK2 inhibitor, unlocks tunable control of BMP signaling for organoid engineering and non-small cell lung cancer research. This thought-leadership article synthesizes cutting-edge mechanistic insights, recent human organoid system advances, and actionable protocol guidance for translational researchers, referencing APExBIO's DMH-1 and the latest literature.

• Octanoic Acid Nutrition Modulates IBD via PPARγ/STAT-1/STAT-

  2026-05-08

  This study demonstrates that octanoic acid-rich enteral nutrition alleviates inflammatory bowel disease by regulating intestinal macrophage polarization through the PPARγ/STAT-1/STAT-6 signaling axis. The findings highlight the mechanistic role of PPARγ in immune modulation and offer a molecular basis for nutritional interventions in IBD management.

• T-5224: Applied Workflows for C-Fos/AP-1 Inhibition in Infla

  2026-05-08

  T-5224, a selective C-Fos/AP-1 inhibitor from APExBIO, transforms arthritis and neuroinflammation research by enabling precise modulation of MMPs and pro-inflammatory cytokines. With robust in vitro and in vivo validation, it delivers reproducible results in models where AP-1 signaling drives pathology.

• Fluorouracil in Solid Tumor Research: Protocols & Optimizati

  2026-05-07

  Fluorouracil (Adrucil) from APExBIO delivers reproducible inhibition of DNA replication in solid tumor models, with validated protocols supporting colon and breast cancer research. This guide translates mechanistic insights and recent breakthroughs into stepwise workflows and troubleshooting strategies that maximize data quality and translational impact.

• Rapid Modulation of Depression-like Behaviors via PrLGlu/avB

  2026-05-07

  A recent study reveals that activating the PrLGlu/avBNSTGABA neural circuit in male mice swiftly alleviates depression-like behaviors, highlighting the circuit’s mechanistic role and its potential as a therapeutic target. This work leverages chemogenetic and optogenetic tools to dissect circuit function, providing valuable insights for translational neuroscience and circuit-level intervention strategies.

• Ceramide-Mediated Lipid Remodeling in Fish Nodavirus Infecti

  2026-05-06

  This study uses comprehensive lipidomic profiling to reveal how ceramide metabolism is manipulated by red-spotted grouper nervous necrosis virus (RGNNV) to promote viral replication in fish cells. By identifying ceramide synthesis as a pro-viral mediator—especially via autophagy—this research provides a mechanistic basis for targeting sphingolipid pathways in antiviral strategies.

• Patient-Derived Gastric Cancer Assembloids: Modeling Microen

  2026-05-06

  The referenced study introduces a novel gastric cancer assembloid model that integrates matched tumor organoids with autologous stromal cell subpopulations, better recapitulating patient tumor heterogeneity and microenvironment. This innovation enables more physiologically relevant preclinical drug testing and advances the understanding of stromal contributions to drug resistance and personalized therapy design.

• Optimizing BET Bromodomain Assays with (-)-JQ1 Stereoisomer

  2026-05-05

  (-)-JQ1 is a rigorously validated, stereospecific negative control enabling precise dissection of BET bromodomain functions in epigenetics and cancer biology research. This article details practical workflows, troubleshooting strategies, and protocol enhancements for researchers leveraging (-)-JQ1 to maximize assay specificity and data reliability.

• Nirmatrelvir (PF-07321332) Workflows for SARS-CoV-2 Inhibiti

  2026-05-05

  Nirmatrelvir (PF-07321332) enables targeted SARS-CoV-2 replication inhibition in both cellular and biochemical assays, streamlining COVID-19 antiviral therapeutics research. This guide translates the latest structural and mechanistic insights into actionable protocols, troubleshooting advice, and experimental best practices for researchers leveraging APExBIO's gold-standard inhibitor.

• Neurotensin (CAS 39379-15-2): Unraveling GPCR and miRNA Path

  2026-05-04

  Explore how Neurotensin, a potent Neurotensin receptor 1 activator, drives next-generation studies in GPCR trafficking and miRNA modulation. This article delivers a unique, in-depth look at assay reliability, spectral interference, and methodological advances for gastrointestinal research.

• Apoptotic Sensitivity in Glioblastoma: Targeting BCL-XL and

  2026-05-04

  This article reviews a recent study demonstrating that glioblastoma (GBM) cells, especially those with stem-like properties, are highly sensitive to apoptosis when anti-apoptotic BCL-XL and MCL-1 proteins are inhibited. The findings highlight the therapeutic promise of selective BH3-mimetics in overcoming treatment resistance in GBM, with implications for targeted apoptosis induction strategies.

• HyperFluor 488 Goat Anti-Human IgG Antibody: Workflow Optimi

  2026-05-03

  HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody distinguishes itself by delivering exceptional signal amplification and reproducibility in advanced immunofluorescence, Western blot, and flow cytometry applications. Optimized for sensitive detection of human immunoglobulins, it empowers translational researchers to extend applications from routine immunoassays to high-complexity studies involving emerging viral targets.

• Biomimetic Chromatography for Modeling Pulmonary Drug Permea

  2026-05-02

  This study benchmarks biomimetic open tubular capillary electrochromatography and immobilised artificial membrane chromatography, both MS-coupled, for assessing pulmonary drug permeability. The findings highlight robust, high-throughput metrics for permeability screening, with relevance to antiretroviral drug research and pharmacokinetic modeling.

• Applied Workflows with EZ Cap™ Cy5 EGFP mRNA (5-moUTP)

  2026-05-01

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) delivers unmatched dual-fluorescence tracking and translation efficiency in real-time, simplifying both nanoparticle optimization and innate immunity suppression research. APExBIO’s rigorously engineered capped, Cy5-labeled mRNA sets a new benchmark for quantitative gene delivery workflows and troubleshooting translational bottlenecks.

• (-)-JQ1 as a Precision Control: Dissecting BET Inhibition in

  2026-05-01

  Explore the distinct role of (-)-JQ1, the JQ1 stereoisomer, in epigenetics research and cancer biology. This in-depth article uniquely bridges practical assay design with mechanistic insight from recent advances in HPV-associated cancer studies.

15060 records 1/1004 page Next 12345 下5页 Last page